[go: up one dir, main page]

YU48400A - Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati - Google Patents

Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati

Info

Publication number
YU48400A
YU48400A YU48400A YU48400A YU48400A YU 48400 A YU48400 A YU 48400A YU 48400 A YU48400 A YU 48400A YU 48400 A YU48400 A YU 48400A YU 48400 A YU48400 A YU 48400A
Authority
YU
Yugoslavia
Prior art keywords
gastroprotected
omeprazole
pharmaceutical preparations
obtaining same
layer containing
Prior art date
Application number
YU48400A
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9522415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU48400(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm filed Critical Ethypharm
Publication of YU48400A publication Critical patent/YU48400A/sh
Publication of RS50245B publication Critical patent/RS50245B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Pronalazak se odnosi na mikrogranule omeprazola od kojih svaka sadrži aktivni sloj koji sadrži aktivni princip, i spoljašnji gastroprotektivni sloj koji sadrži gastroprotekcioni agens, koje se karakterišu time što se omeprazol kombinuje sa najmanje jednom hidrofobnom supstancom.[The invention concerns omeprazole microgranules each comprising an active layer containing the active principle, and an outer gastroprotecting layer containing a gastroprotecting agent, characterised in that the omeprazole is combined with at least a hydrophobic substance.
YU48400A 1998-01-30 1998-08-10 Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati RS50245B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801098A FR2774288B1 (fr) 1998-01-30 1998-01-30 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (2)

Publication Number Publication Date
YU48400A true YU48400A (sh) 2003-02-28
RS50245B RS50245B (sr) 2009-07-15

Family

ID=9522415

Country Status (31)

Country Link
US (1) US6551621B1 (sh)
EP (1) EP1051174B2 (sh)
JP (1) JP4286452B2 (sh)
KR (1) KR100510366B1 (sh)
CN (1) CN1114405C (sh)
AT (1) ATE232100T1 (sh)
AU (1) AU755882B2 (sh)
BG (1) BG65087B1 (sh)
BR (1) BR9814924B1 (sh)
CA (1) CA2319015C (sh)
CZ (1) CZ299192B6 (sh)
DE (1) DE69811278T3 (sh)
DK (1) DK1051174T4 (sh)
EA (1) EA002879B1 (sh)
EE (1) EE05620B1 (sh)
ES (1) ES2189232T5 (sh)
FR (1) FR2774288B1 (sh)
GE (1) GEP20032941B (sh)
HU (1) HU229956B1 (sh)
IL (1) IL137536A0 (sh)
IS (1) IS2866B (sh)
NO (1) NO330144B1 (sh)
NZ (1) NZ505998A (sh)
PL (1) PL200043B1 (sh)
PT (1) PT1051174E (sh)
RS (1) RS50245B (sh)
SI (1) SI1051174T2 (sh)
SK (1) SK285666B6 (sh)
TR (1) TR200002214T2 (sh)
UA (1) UA61988C2 (sh)
WO (1) WO1999038511A1 (sh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1603537A4 (en) * 2003-02-20 2009-11-04 Santarus Inc NOVEL FORMULATION, ANTICIPATED COMPLEX IMMEDIATE RELEASE FOR A FAST AND CONTINUOUS SUPPRESSION OF MAGIC ACID
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
AR045062A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN1874764B (zh) * 2003-10-10 2012-08-01 埃法尔姆公司 含有银杏提取物的持续释放微粒及其制备方法
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US20050249806A1 (en) * 2004-02-10 2005-11-10 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
MXPA06011820A (es) * 2004-04-16 2006-12-15 Santarus Inc Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico.
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP5563735B2 (ja) * 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
JP5844028B2 (ja) 2006-04-04 2016-01-13 ケージー アクキュイシチオン エルエルシー 抗血小板薬及び酸阻害薬を含む経口剤形
AU2007266574A1 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008047320A2 (en) * 2006-10-17 2008-04-24 Ranbaxy Laboratories Limited Multiple unit tablet compositions of benzimidazole compounds
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US12472149B2 (en) 2015-07-17 2025-11-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
EP3117824A1 (en) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
HRP20230250T1 (hr) 2015-07-17 2023-04-14 BE Pharbel Manufacturing Višeslojni farmaceutski aktivne mikročestice, koje otpuštaju spoj u tekućem obliku doziranja
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
WO1996010624A1 (en) * 1994-09-30 1996-04-11 Medical Security Corporation Method and system for cleaning and slip-resistant treatment of surface coverings
ES2094694B1 (es) † 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
DK1308159T3 (da) * 1995-09-21 2005-02-14 Pharma Pass Ii Llc Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf
ZA979937B (en) * 1996-11-06 1999-05-18 Sharmatek Inc Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I

Also Published As

Publication number Publication date
SK11412000A3 (sk) 2001-04-09
HUP0100347A3 (en) 2002-12-28
IS2866B (is) 2014-01-15
CZ299192B6 (cs) 2008-05-14
SI1051174T2 (sl) 2013-01-31
DK1051174T4 (da) 2012-10-01
WO1999038511A1 (fr) 1999-08-05
CN1284877A (zh) 2001-02-21
FR2774288B1 (fr) 2001-09-07
EP1051174B2 (fr) 2012-07-04
DE69811278T3 (de) 2012-11-29
BR9814924A (pt) 2000-10-17
EP1051174B1 (fr) 2003-02-05
PT1051174E (pt) 2003-06-30
NO20004654D0 (no) 2000-09-18
AU755882B2 (en) 2003-01-02
ES2189232T5 (es) 2012-11-07
DE69811278T2 (de) 2003-11-27
DE69811278D1 (de) 2003-03-13
HK1032354A1 (en) 2001-07-20
KR20010040502A (ko) 2001-05-15
CA2319015A1 (fr) 1999-08-05
AU9074898A (en) 1999-08-16
NO20004654L (no) 2000-09-18
EP1051174A1 (fr) 2000-11-15
EE200000466A (et) 2002-04-15
BR9814924B1 (pt) 2010-07-13
RS50245B (sr) 2009-07-15
UA61988C2 (uk) 2003-12-15
JP2002501895A (ja) 2002-01-22
HU229956B1 (hu) 2015-03-02
IS5577A (is) 2000-07-25
BG104634A (bg) 2001-02-28
FR2774288A1 (fr) 1999-08-06
DK1051174T3 (da) 2003-05-26
SI1051174T1 (sl) 2003-06-30
ES2189232T3 (es) 2003-07-01
TR200002214T2 (tr) 2000-12-21
KR100510366B1 (ko) 2005-08-24
EA002879B1 (ru) 2002-10-31
PL200043B1 (pl) 2008-11-28
IL137536A0 (en) 2001-07-24
CN1114405C (zh) 2003-07-16
NO330144B1 (no) 2011-02-21
SK285666B6 (sk) 2007-05-03
EA200000797A1 (ru) 2001-02-26
EE05620B1 (et) 2013-02-15
US6551621B1 (en) 2003-04-22
GEP20032941B (en) 2003-04-25
CA2319015C (fr) 2008-08-05
NZ505998A (en) 2003-11-28
PL342044A1 (en) 2001-05-21
BG65087B1 (bg) 2007-02-28
HUP0100347A2 (hu) 2001-10-28
CZ20002709A3 (cs) 2000-12-13
JP4286452B2 (ja) 2009-07-01
ATE232100T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
YU48400A (sh) Gastroprotektovane mikrogranule omeprazola, postupak za proizvodnju i farmaceutski preparati
NO20003051D0 (no) Metode for administrering av AspB28-humant insulin
EP0731712A4 (en) PHYSIOLOGICALLY STABLE COMPOSITIONS OF BUTYRIC ACID, SALTS AND BUTYRIC ACID DERIVATIVES AS ANTINEOPLASTIC AGENTS
ATE243516T1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
FI952607A7 (fi) Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi
FI19991970L (fi) Hitaasti vapauttava kapseli ja hitaasti vapauttavia formulaatioita
NL990007I2 (nl) Benzimidazolen, deze verbindingen bevattende geneesmiddelen en werkwijze voor hun bereiding.
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
NO20010535L (no) Todelt kapsel for opptak av farmasøytiske preparater for pulverinhalatorer
IS3660A7 (is) Læknisfræðilega virk klóró-súbstitúreuð bensimidazole, aðferð við framleiðslu þeirra og notkun
NO164977C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske substituert-fenoksyalkylisoksazoler og -furaner.
FI970967A7 (fi) Heterosyklinen johdannainen ja lääkeaine
FI932553A7 (fi) Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
FR2774910B1 (fr) Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
NO20020243D0 (no) Lavdosetabletter og fremgangsmåte til fremstilling
FI880210L (fi) Menetelmä valmistaa peroraalista stabiloitua, tehoainetta hidastetusti ja kontrolloidusti vapauttavaa, lääkevalmistetta
NO20000376D0 (no) Transdermalt terapeutisk system for frigiving av virkestoff gjennom huden inn i en organisme og fremgangsmåte for påfoering på huden
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
PT1206253E (pt) Preparacoes farmaceuticas solidas contendo nanossois de quitosano e metodo de preparacao
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
PL352041A1 (en) Derivatives of isochynoline, pharmaceutical compositions containing these derivatives and method of obtaining an active substance
FI991115A0 (fi) Menetelmä oraalisesti elimistöön tuotavan ravinteen tai muun fysiologisesti vaikuttavan aineen maittavuuden biokyberneettiseksi manipuloimiseksi sekä menetelmän käyttämiseen liittyvä valmiste
DE68926469D1 (de) Alkaloid-Verbindungen, pharmazeutische Zubereitungen und Verwendungsmethode
IT8721769A0 (it) Tioderivati beta-lattamici farmacologicamente attivi eprocedimento per la loro preparazione.